Do you want to read an article? Please log in or register.
Evinacumab for Homozygous Familial Hypercholesterolemia
Heart, Artery and Coronary DiseasesLipid-Lowering Drugs
RECOMMENDED
Related content
Cardiovascular Risk and DiseasesHeart, Artery and Coronary DiseasesLipid-Lowering Drugs
Efficacy of Rosuvastatin in Children With Homozygous Familial Hypercholesterolemia and Association With Underlying Genetic Mutations
J Am Coll Cardiol.
Stein EA, Dann EJ, Wiegman A, Skovby F, Gaudet D, Sokal E, Charng MJ, Mohamed M, Luirink I, Raichlen JS, Sundén M, Carlsson SC, Raal FJ, Kastelein JJP
doi: 10.1016/j.jacc.2017.06.058.
Cardiovascular Risk and DiseasesHeart, Artery and Coronary DiseasesLipid-Lowering Drugs
Statins for children with familial hypercholesterolemia
Cochrane Database Syst Rev.
Vuorio A, Kuoppala J, Kovanen PT, Humphries SE, Tonstad S, Wiegman A, Drogari E, Ramaswami U
doi: 10.1002/14651858.
Heart, Artery and Coronary DiseasesLipid-Lowering Drugs
Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children with Heterozygous Familial Hypercholesterolemia: The CHARON Study
Circulation.
Braamskamp MJAM, Langslet G, McCrindle BW, Cassiman DM, Francis GA, Gagne C, Gaudet D, Morrison KM, Wiegman A, Turner T, Miller E, Kusters DM, Raichlen JS, Martin PD, Stein EA, Kastelein JJP, Hutten BA
doi: 10.1161/CIRCULATIONAHA.
COMMENTED
Heart, Artery and Coronary Diseases
Reducing the Clinical and Public Health Burden of Familial Hypercholesterolemia: A Global Call to Action
★ 3
Recommended and commented by
Prof. Dr Isabella Sudano, Faculty Member
doi: 10.1001/jamacardio.2019.5173.
RECOMMENDED
Lipid-Lowering Drugs
Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia
★ 3
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
N Engl J Med.
Raal FJ, Kallend D, Ray KK, Turner T, Koenig W, Wright RS, Wijngaard PLJ, Curcio D, Jaros MJ, Leiter LA, Kastelein JJP, ORION-9 Investigators.
doi: 10.1056/NEJMoa1913805.
Heart, Artery and Coronary DiseasesLipid-Lowering Drugs
Does Evolocumab, as a PCSK9 Inhibitor, Ameliorate the Lipid Profile in Familial Hypercholesterolemia Patients? A Meta-Analysis of Randomized Controlled Trials
J Pharm Pharm Sci.
Eslami SM, Nikfar S, Ghasemi M, Abdollahi M
doi: 10.18433/J36C8N.
Cardiovascular Risk and DiseasesLipid-Lowering Drugs
Long-term treatment with evolocumab added to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesterolaemia: an interim subset analysis of the open-label TAUSSIG study
Lancet Diabetes Endocrinol.
Raal FJ, Hovingh GK, Blom D, Santos RD, Harada-Shiba M, Bruckert E, Couture P, Soran H, Watts GF, Kurtz C, Honarpour N, Tang L, Kasichayanula S, Wasserman SM, Stein EA
doi: 10.1016/S2213-8587
RECOMMENDED
Heart, Artery and Coronary DiseasesLipid-Lowering Drugs
Long-Term Evolocumab in Patients With Familial Hypercholesterolemia
★ 3
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
J Am Coll Cardiol.
Santos RD, Stein EA, Hovingh GK, Blom DJ, Soran H, Watts GF, López JAG, Bray S, Kurtz CE, Hamer AW, Raal FJ
doi: 10.1016/j.jacc.2019.12.020.
RECOMMENDED
Heart, Artery and Coronary Diseases
Association of Low-Density Lipoprotein Cholesterol With Risk of Aortic Valve Stenosis in Familial Hypercholesterolemia
★ 3
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
JAMA Cardiol.
Mundal LJ, Hovland A, Igland J, Veierød MB, Holven KB, Bogsrud MP, Tell GS, Leren TP, Retterstøl K
doi: 10.1001/jamacardio.2019.3903.